{
  "permutation_id": "P8",
  "description": "AC-SINS reclassification",
  "reclassification_strategy": "R5",
  "removal_strategy": "S1",
  "reclassified_ids": [
    "bavituximab",
    "bimagrumab",
    "drozitumab",
    "infliximab",
    "tremelimumab"
  ],
  "removed_ids": [
    "lirilumab",
    "basiliximab",
    "glembatumumab",
    "urelumab",
    "nimotuzumab",
    "olaratumab",
    "pembrolizumab",
    "atezolizumab",
    "ipilimumab",
    "ocrelizumab",
    "tralokinumab",
    "rituximab",
    "eldelumab",
    "fezakinumab",
    "seribantumab",
    "tigatuzumab",
    "dinutuximab",
    "enokizumab",
    "ganitumab",
    "lumiliximab",
    "bevacizumab",
    "benralizumab",
    "siltuximab",
    "tabalumab",
    "nivolumab",
    "lebrikizumab",
    "crenezumab",
    "galiximab",
    "veltuzumab",
    "tovetumab"
  ],
  "confusion_matrix": [
    [
      42,
      17
    ],
    [
      11,
      16
    ]
  ],
  "accuracy": 0.6744186046511628,
  "exact_match": false,
  "timestamp": "2025-11-03T23:11:04.665714"
}